AGuIX


Journal

The British journal of radiology
ISSN: 1748-880X
Titre abrégé: Br J Radiol
Pays: England
ID NLM: 0373125

Informations de publication

Date de publication:
Jan 2019
Historique:
pubmed: 19 9 2018
medline: 15 5 2020
entrez: 19 9 2018
Statut: ppublish

Résumé

AGuIX

Identifiants

pubmed: 30226413
doi: 10.1259/bjr.20180365
pmc: PMC6435081
doi:

Substances chimiques

Radiation-Sensitizing Agents 0
Gadolinium AU0V1LM3JT

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

20180365

Références

Phys Med Biol. 2018 Jan 09;63(2):02TR01
pubmed: 29125831
Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):189-205
pubmed: 26700713
Sci Rep. 2016 Jul 20;6:29936
pubmed: 27435424
J Nanobiotechnology. 2016 Jul 25;14(1):60
pubmed: 27455834
ACS Nano. 2011 Dec 27;5(12):9566-74
pubmed: 22040385
Adv Drug Deliv Rev. 2017 Jan 1;108:25-38
pubmed: 27137110
Sci Rep. 2016 Sep 23;6:34040
pubmed: 27658637
Angew Chem Int Ed Engl. 2011 Dec 16;50(51):12299-303
pubmed: 22057640
Nat Biotechnol. 2007 Oct;25(10):1165-70
pubmed: 17891134
Nanoscale. 2016 Jan 7;8(1):581-9
pubmed: 26645621
Cancer Radiother. 2015 Oct;19(6-7):508-14
pubmed: 26343033
Chem Rev. 2015 Feb 25;115(4):1990-2042
pubmed: 25602130
Nat Biotechnol. 2010 Dec;28(12):1300-3
pubmed: 21057497
Contrast Media Mol Imaging. 2016 Sep;11(5):396-404
pubmed: 27396584
J Neurooncol. 2011 Jun;103(2):317-24
pubmed: 20845061
Nano Lett. 2017 Mar 8;17(3):1733-1740
pubmed: 28145723
Nanomedicine (Lond). 2017 Jul;12(13):1561-1574
pubmed: 28621567
Nanomedicine (Lond). 2016 Sep;11(18):2405-17
pubmed: 27529506
Nanoscale Res Lett. 2017 Sep 6;12(1):523
pubmed: 28875472
Theranostics. 2015 Jun 11;5(9):1030-44
pubmed: 26155318
Nanotechnology. 2010 Feb 26;21(8):85103
pubmed: 20101074
Quant Imaging Med Surg. 2017 Feb;7(1):88-122
pubmed: 28275562
Nanomedicine (Lond). 2017 Jul;12(14):1675-1687
pubmed: 28635419
Nanomedicine. 2014 Nov;10(8):1751-5
pubmed: 24941464
J Nanosci Nanotechnol. 2011 Sep;11(9):7833-9
pubmed: 22097494
Sci Rep. 2016 Oct 11;6:35053
pubmed: 27725693
NMR Biomed. 2015 Jun;28(6):738-46
pubmed: 25921808
Inorg Chem. 2003 Apr 7;42(7):2342-9
pubmed: 12665368
Nanomedicine (Lond). 2013 Mar;8(3):449-67
pubmed: 23477336
Clin Cancer Res. 2010 Dec 15;16(24):6139-49
pubmed: 20876255
Nanomedicine. 2014 Nov;10(8):1887-95
pubmed: 24972007
Nanomedicine. 2017 Nov;13(8):2655-2660
pubmed: 28779947
Radiother Oncol. 2017 Sep;124(3):344-356
pubmed: 28784439
Chemistry. 2013 May 3;19(19):6122-36
pubmed: 23512788
Nanomedicine. 2014 Nov;10(8):1601-8
pubmed: 24846523
Contrast Media Mol Imaging. 2016 Sep;11(5):381-395
pubmed: 27435658
Int J Nanomedicine. 2016 Apr 15;11:1549-56
pubmed: 27143877
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014 Nov-Dec;6(6):559-73
pubmed: 25196203
Cancer Nanotechnol. 2014;5(1):6
pubmed: 25328549
Curr Med Chem. 2012;19(6):781-92
pubmed: 22214454
Cancer Nanotechnol. 2014;5(1):4
pubmed: 26561512
Nanomedicine. 2015 Jan;11(1):247-57
pubmed: 24983891
ACS Chem Neurosci. 2011 Mar 16;2(3):118-40
pubmed: 22778862
Int J Toxicol. 2012 Nov-Dec;31(6):584-94
pubmed: 23212452
World J Gastroenterol. 2015 Dec 21;21(47):13400-2
pubmed: 26715826
Radiat Oncol J. 2016 Sep;34(3):230-238
pubmed: 27730800
Sci Transl Med. 2014 Oct 29;6(260):260ra149
pubmed: 25355699
Radiat Res. 1980 Oct;84(1):144-8
pubmed: 7454977
MAGMA. 2014 Aug;27(4):303-16
pubmed: 24170416
Clin Cancer Res. 2017 Feb 15;23(4):908-917
pubmed: 27998887
Nanomedicine (Lond). 2016 May;11(9):997-9
pubmed: 27074108
Sci Rep. 2016 Jul 14;6:29678
pubmed: 27411781
Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):9247-52
pubmed: 24927562
Theranostics. 2016 Jan 20;6(3):418-27
pubmed: 26909115
Mol Pharm. 2016 Jul 5;13(7):2596-601
pubmed: 27266800
J Control Release. 2016 Sep 28;238:103-113
pubmed: 27423325
Small. 2015 Jan 14;11(2):215-21
pubmed: 25201285
Cancer Nanotechnol. 2017;8(1):9
pubmed: 29213338
Bioconjug Chem. 2013 Sep 18;24(9):1584-97
pubmed: 23978076
Magn Reson Med. 2013 Nov;70(5):1419-26
pubmed: 23233439
Cancer Nanotechnol. 2015;6(1):4
pubmed: 26345984
ACS Nano. 2015 Mar 24;9(3):2477-88
pubmed: 25703068
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Jan;9(1):
pubmed: 27312983
Angew Chem Int Ed Engl. 2010 Nov 8;49(46):8649-52
pubmed: 20886481
Invest Radiol. 2017 Dec;52(12):725-733
pubmed: 28678084
Theranostics. 2017 Jan 5;7(2):436-451
pubmed: 28255341
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 Jan-Feb;8(1):23-45
pubmed: 25903643
Nanoscale. 2016 Jun 9;8(23):12054-65
pubmed: 27244570
Br J Radiol. 2014 Sep;87(1041):20140134
pubmed: 24990037
Brain Sci. 2018 Jan 16;8(1):
pubmed: 29337870
Sci Rep. 2011;1:18
pubmed: 22355537
Anal Chem. 2013 Nov 5;85(21):10440-7
pubmed: 24160370

Auteurs

François Lux (F)

NH TherAguix SAS, Villeurbanne, France.
Univ Lyon Université Claude Bernard Lyon 1, CNRS, Institut Lumière Matière, LYON, France.

Vu Long Tran (VL)

Univ Lyon Université Claude Bernard Lyon 1, CNRS, Institut Lumière Matière, LYON, France.
Nano-H SAS, Saint-Quentin-Fallavier, France.

Eloïse Thomas (E)

Univ Lyon Université Claude Bernard Lyon 1, CNRS, Institut Lumière Matière, LYON, France.

Sandrine Dufort (S)

NH TherAguix SAS, Villeurbanne, France.

Fabien Rossetti (F)

Univ Lyon Université Claude Bernard Lyon 1, CNRS, Institut Lumière Matière, LYON, France.

Matteo Martini (M)

Univ Lyon Université Claude Bernard Lyon 1, CNRS, Institut Lumière Matière, LYON, France.

Charles Truillet (C)

Imagerie Moléculaire In Vivo, Inserm, CEA, CNRS, Univ Paris Sud, Université Paris Saclay - Service Hospitalier Frédéric Joliot, Orsay, France.

Tristan Doussineau (T)

NH TherAguix SAS, Villeurbanne, France.

Guillaume Bort (G)

Univ Lyon Université Claude Bernard Lyon 1, CNRS, Institut Lumière Matière, LYON, France.

Franck Denat (F)

Institut de Chimie Moléculaire, Université de Bourgogne, Dijon, France.

Frédéric Boschetti (F)

CheMatech, Faculté des Sciences Mirande, Dijon, France.

Goran Angelovski (G)

MR Neuroimaging Agents, Max Planck Institute for Biological Cybernetics, Tuebingen, Germany.

Alexandre Detappe (A)

Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, MA, USA.

Yannick Crémillieux (Y)

Centre de Résonance Magnétique des Systèmes Biologiques, CNRS UMR, Université Bordeaux, Bordeaux, France.

Nathalie Mignet (N)

Chimie ParisTech, PSL Research University, Unité de Technologies Chimiques et Biologiques pour la Santé (UTCBS), Paris, France.
CNRS, UTCBS UMR , Paris, France.
Université Paris Descartes Sorbonne-Paris-Cité, Paris, France.
INSERM, UTCBS U 1022, Paris, France.

Bich-Thuy Doan (BT)

Chimie ParisTech, PSL Research University, Unité de Technologies Chimiques et Biologiques pour la Santé (UTCBS), Paris, France.
CNRS, UTCBS UMR , Paris, France.
Université Paris Descartes Sorbonne-Paris-Cité, Paris, France.
INSERM, UTCBS U 1022, Paris, France.

Benoit Larrat (B)

NeuroSpin, CEA Saclay, Gif-sur-Yvette, France.
Université Paris-Saclay, Orsay, France.

Sébastien Meriaux (S)

NeuroSpin, CEA Saclay, Gif-sur-Yvette, France.
Université Paris-Saclay, Orsay, France.

Emmanuel Barbier (E)

INSERM, Univ. Grenoble Alpes, Grenoble Institut des Neurosciences , Grenoble, France.

Stéphane Roux (S)

Institut UTINAM, UMR CNRS 6213-Université de Bourgogne Franche-Comté, Besançon, France.

Peter Fries (P)

Clinic of Diagnostic and Interventional Radiology, Saarland University Medical Center, Homburg/Saar, Germany.

Andreas Müller (A)

Clinic of Diagnostic and Interventional Radiology, Saarland University Medical Center, Homburg/Saar, Germany.

Marie-Caline Abadjian (MC)

Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Carolyn Anderson (C)

Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Emmanuelle Canet-Soulas (E)

Univ Lyon, CarMeN Laboratory Institut National de la Santé et de la Recherche Médicale U1060,INRA U1397, Université Lyon 1, INSA Lyon, Oullins, France.

Penelope Bouziotis (P)

Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Center forScientific Research "Demokritos", Aghia Paraskevi, Athens, Greece.

Muriel Barberi-Heyob (M)

Université de Lorraine, CNRS, CRAN, Nancy, France.

Céline Frochot (C)

Laboratoire Réactions et Génie des Procédés, UMR, Université de Lorraine-CNRS, Nancy, France.

Camille Verry (C)

Radiotherapy department, CHU de Grenoble, Grenoble cedex 9, France.

Jacques Balosso (J)

Radiotherapy department, CHU de Grenoble, Grenoble cedex 9, France.

Michael Evans (M)

Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, USA.

Jacqueline Sidi-Boumedine (J)

UNIV Lyon - Université Claude Bernard Lyon 1, Villeurbanne, France.

Marc Janier (M)

UNIV Lyon - Université Claude Bernard Lyon 1, Villeurbanne, France.
Hospices Civils de Lyon, plateforme Imthernat, Hôpital Edouard Herriot, Lyon, France.

Karl Butterworth (K)

Centre for Cancer Research and Cell Biology Queen's University Belfast,, Belfast BT9 7AE, UK.

Stephen McMahon (S)

Centre for Cancer Research and Cell Biology Queen's University Belfast,, Belfast BT9 7AE, UK.

Kevin Prise (K)

Centre for Cancer Research and Cell Biology Queen's University Belfast,, Belfast BT9 7AE, UK.

Marie-Thérèse Aloy (MT)

IPNL, PRISME, Laboratoire de Radiobiologie Cellulaire et Moléculaire, Faculté de Médecine Lyon-Sud, Université Lyon 1; Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.

Dominique Ardail (D)

IPNL, PRISME, Laboratoire de Radiobiologie Cellulaire et Moléculaire, Faculté de Médecine Lyon-Sud, Université Lyon 1; Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.

Claire Rodriguez-Lafrasse (C)

IPNL, PRISME, Laboratoire de Radiobiologie Cellulaire et Moléculaire, Faculté de Médecine Lyon-Sud, Université Lyon 1; Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.

Erika Porcel (E)

ISMO UMR, Université Paris Saclay, Université Paris Sud, CNRS, Orsay cedex, France.

Sandrine Lacombe (S)

ISMO UMR, Université Paris Saclay, Université Paris Sud, CNRS, Orsay cedex, France.

Ross Berbeco (R)

Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, MA, USA.

Awatef Allouch (A)

Cell death and Aging team, Gustave Roussy, rue Edouard Vaillant, Villejuif, France.
Laboratory of Molecular Radiotherapy INSERM, Gustave Roussy, rue Edouard Vaillant, Villejuif, France.
Gustave Roussy, rue Edouard Vaillant, Villejuif, France.
Université Paris Sud - Paris , rue Edouard Vaillant, Villejuif, France.

Jean-Luc Perfettini (JL)

Cell death and Aging team, Gustave Roussy, rue Edouard Vaillant, Villejuif, France.
Laboratory of Molecular Radiotherapy INSERM, Gustave Roussy, rue Edouard Vaillant, Villejuif, France.
Gustave Roussy, rue Edouard Vaillant, Villejuif, France.
Université Paris Sud - Paris , rue Edouard Vaillant, Villejuif, France.

Cyrus Chargari (C)

French Military Health Academy, Ecole du Val-de-Grâce, Paris, France.
Institut de Recherche Biomédicale des Armées, Bretigny-sur-Orge, France.
Radiotherapy Department, Gustave Roussy, Villejuif, France.
Brachytherapy Unit, Gustave Roussy Cancer Campus, Villejuif, France.

Eric Deutsch (E)

Radiotherapy Department, Gustave Roussy, Villejuif, France.
Brachytherapy Unit, Gustave Roussy Cancer Campus, Villejuif, France.

Géraldine Le Duc (G)

NH TherAguix SAS, Villeurbanne, France.

Olivier Tillement (O)

NH TherAguix SAS, Villeurbanne, France.
Univ Lyon Université Claude Bernard Lyon 1, CNRS, Institut Lumière Matière, LYON, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH